# Satomi Watanabe

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/satomi-watanabe/

## Facts

| Field | Value |
| --- | --- |
| Citations | 888 |
| Field | HER2/EGFR in Cancer Research |
| h-index | 14 |
| i10-index | 22 |
| Last Known Institution | Kishiwada City Hospital |
| OpenAlex ID | https://openalex.org/A5058195283 |
| ORCID iD | 0000-0002-0487-8721 |
| Works | 133 |

## Researcher papers

- [An HER3-targeting antibody–drug conjugate incorporating a DNA topoisomerase I inhibitor U3-1402 conquers EGFR tyrosine kinase inhibitor-resistant NSCLC](https://scholariq.org/papers/an-her3-targeting-antibody-drug-conjugate-incorporating-a-dna-topoisomerase-i/)
- [Clinical Application of the FoundationOne CDx Assay to Therapeutic Decision-Making for Patients with Advanced Solid Tumors](https://scholariq.org/papers/clinical-application-of-the-foundationone-cdx-assay-to-therapeutic-decision/)
- [Targeting of the HER2/HER3 signaling axis overcomes ligand‐mediated resistance to trastuzumab in HER2‐positive breast cancer](https://scholariq.org/papers/targeting-of-the-her2-her3-signaling-axis-overcomes-ligand-mediated-resistance/)
- [HER2 genomic amplification in circulating tumor DNA from patients with cetuximab-resistant colorectal cancer](https://scholariq.org/papers/her2-genomic-amplification-in-circulating-tumor-dna-from-patients-with-cetuximab/)
- [Anthocyanin production in suspension cultures of high-producing cells of Euphorbia millii.](https://scholariq.org/papers/anthocyanin-production-in-suspension-cultures-of-high-producing-cells-of/)
- [Mutational activation of the epidermal growth factor receptor down‐regulates major histocompatibility complex class I expression via the extracellular signal‐regulated kinase in non–small cell lung cancer](https://scholariq.org/papers/mutational-activation-of-the-epidermal-growth-factor-receptor-down-regulates/)
- [Progression-Free and Overall Survival of Patients With ALK Rearrangement–Positive Non–Small Cell Lung Cancer Treated Sequentially With Crizotinib and Alectinib](https://scholariq.org/papers/progression-free-and-overall-survival-of-patients-with-alk-rearrangement/)
- [Changes in lignin content of leaf litters during mulching](https://scholariq.org/papers/changes-in-lignin-content-of-leaf-litters-during-mulching/)
- [Two cases of EGFR mutation-positive lung adenocarcinoma that transformed into squamous cell carcinoma: successful treatment of one case with rociletinib](https://scholariq.org/papers/two-cases-of-egfr-mutation-positive-lung-adenocarcinoma-that-transformed-into/)
- [T790M-Selective EGFR-TKI Combined with Dasatinib as an Optimal Strategy for Overcoming EGFR-TKI Resistance in T790M-Positive Non–Small Cell Lung Cancer](https://scholariq.org/papers/t790m-selective-egfr-tki-combined-with-dasatinib-as-an-optimal-strategy-for/)
- [EP.06B.14 Differential Expression in Potential Therapeutic Target Protein by Treatment in Small Cell Lung Cancer with and without Transformation](https://scholariq.org/papers/ep-06b-14-differential-expression-in-potential-therapeutic-target-protein-by/)

## Researcher topics

- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)
- [Fibroblast Growth Factor Research](https://scholariq.org/topics/fibroblast-growth-factor-research/)

## Researcher university

- [Kishiwada City Hospital](https://scholariq.org/institutions/kishiwada-city-hospital/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.